Biotechnology
PHVS
22.50
price up icon1.26%   0.28
after-market Handel nachbörslich: 22.49 -0.01 -0.04%

Pharvaris Nv (PHVS)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$22.22
Offen:
$22.12
24-Stunden-Volumen:
325.77K
Relative Volume:
1.72
Marktkapitalisierung:
$1.43B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-7.9686
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
-1.40%
1M Leistung:
-3.81%
6M Leistung:
+22.48%
1J Leistung:
-6.83%
1-Tages-Spanne:
Value
$21.21
$23.82
1-Wochen-Bereich:
Value
$21.21
$23.82
52-Wochen-Spanne:
Value
$11.51
$26.33

Pharvaris Nv Stock (PHVS) Company Profile

Name
Firmenname
Pharvaris Nv
Name
Sektor
Healthcare (1136)
Name
Branche
Biotechnology (633)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
PHVS's Discussions on Twitter

Vergleichen Sie PHVS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PHVS
Pharvaris Nv
 22.50 1.43B 0 -143.59M -119.47M -2.8236
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-15 Eingeleitet H.C. Wainwright Buy
2025-10-09 Hochstufung BofA Securities Underperform → Neutral
2025-06-11 Eingeleitet Guggenheim Buy
2025-04-29 Eingeleitet Cantor Fitzgerald Overweight
2023-09-25 Eingeleitet Wedbush Outperform
2023-08-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-10-05 Eingeleitet Bryan Garnier Buy
2022-09-13 Fortgesetzt JMP Securities Mkt Outperform
2022-08-23 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-08-22 Herabstufung BofA Securities Neutral → Underperform
2022-05-25 Eingeleitet JMP Securities Mkt Outperform
2021-03-02 Eingeleitet BofA Securities Neutral
2021-03-02 Eingeleitet Morgan Stanley Overweight
2021-03-02 Eingeleitet Oppenheimer Outperform
2021-03-02 Eingeleitet SVB Leerink Outperform
Alle ansehen

Pharvaris Nv Aktie (PHVS) Neueste Nachrichten

pulisher
10:05 AM

Full technical analysis of Pharvaris N.V. stockJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com

10:05 AM
pulisher
09:37 AM

Custom watchlist performance reports with Pharvaris N.V.Trade Risk Report & Low Risk High Reward Ideas - newser.com

09:37 AM
pulisher
07:57 AM

Can Pharvaris N.V. (9EN) stock deliver strong annual returnsJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com

07:57 AM
pulisher
05:31 AM

How sentiment analysis helps forecast Pharvaris N.V.Sell Signal & Community Consensus Trade Alerts - newser.com

05:31 AM
pulisher
04:13 AM

Technical signs of recovery in Pharvaris N.V.July 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com

04:13 AM
pulisher
03:34 AM

What recovery options are there for Pharvaris N.V.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com

03:34 AM
pulisher
02:29 AM

Is Pharvaris N.V. stock safe for conservative investorsMarket Sentiment Summary & Safe Entry Zone Tips - newser.com

02:29 AM
pulisher
Nov 02, 2025

Will Pharvaris N.V. stock attract ESG investorsBuy Signal & Stock Portfolio Risk Management - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

HC Wainwright & Co. Initiates Coverage of Pharvaris N.V. (PHVS) with Buy Recommendation - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Visual analytics tools that track Pharvaris N.V. performanceJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How forex fluctuations impact Pharvaris N.V. (9EN) stockAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Pharvaris N.V. (9EN) stock undervalued after correctionJuly 2025 Institutional & Growth Focused Entry Reports - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Can Pharvaris N.V. (9EN) stock reach $200 price targetWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Can Pharvaris N.V. stock deliver sustainable ROEJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How Pharvaris N.V. stock compares to market leaders2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Cash per share of Pharvaris N.V. – BER:9EN - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

Will earnings trigger a reversal in Pharvaris N.V.Insider Selling & Low Risk High Win Rate Stock Picks - newser.com

Oct 30, 2025
pulisher
Oct 28, 2025

Institutional Investors May Adopt Severe Steps After Pharvaris N.V.'s (NASDAQ:PHVS) Latest 3.4% Drop Adds to a Year Losses - 富途牛牛

Oct 28, 2025

Finanzdaten der Pharvaris Nv-Aktie (PHVS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie PHVS

biotechnology RPRX
$37.30
price down icon 0.64%
biotechnology GMAB
$28.71
price up icon 0.35%
biotechnology INCY
$101.57
price up icon 8.65%
biotechnology BNTX
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
biotechnology INSM
$186.23
price down icon 1.78%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):